Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Gutzwiller, Jean Pierre ^a   Drewe, Jürgen ^b   Göke, Burkhard ^c,d   Schmidt, Harald ^c   Rohrer, Beat ^a   Lareida, Jürg ^a   Beglinger, Christoph ^b  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Appetite; Brain gut peptides; Obesity

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ADULT; APPETITE; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; FOOD INTAKE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SATIETY;

EID: 0032966882     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.5.r1541     Document Type: Article

References (17)

1. Byrne, M. M., and B. Goke. Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use. Diabet. Med. 13: 854-860, 1996.
2. Drewe, J., A. Gadient, L. C. Rovati, and C. Beglinger. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. Gastroenterology 102: 1654-1659, 1992.
3. Drucker, D. J. Glucagon-like peptides. Diabetes 47: 159-169, 1998.
4. Flint, A., A. Raben, A. Astrup, and J. J. Hoist. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J. Clin. Invest. 101: 515-520, 1998.
5. Gefel, D., Y. Barg, and R. Zimlichman. Glucagon-like peptide-1 structure, function and potential use for NIDDM. Isr. J. Med. Sci. 33: 690-695, 1997.
6. Gutniak, M. K., H. Larsson, S. W. Sanders, O. Juneskans, J. J. Hoist, and B. Ahren. GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions. Diabetes Care 20: 1874-1879, 1997.
7. Gutzwiller, J. P., B. Goeke, J. Drewe, P. Hildebrand, S. Ketterer, D. Handschin, R. Winterhalder, D. Conen, and C. Beglinger. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 44: 81-86, 1999.
8. Hoist, J. J. Enteroglucagon. Anna. Rev. Physiol. 59: 257-271, 1997.
9. Layer, P., J. J. Hoist, D. Grandt, and H. Goebell. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig. Dis. Sci. 40: 1074-1082, 1995.
10. Nauck, M. Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes. Diabet. Med. 13: S39-S43, 1996.
11. Nauck, M. A., N. Kleine, C. Orskov, J. J. Hoist, B. Willms, and W. Creutzfeldt. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 741-744, 1993.
12. Ritzel, R., C. Orskov, J. J. Hoist, and M. A. Nauck. Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response relationships. Diabetologia 38: 720-725, 1995.
13. Schirra, J., K. Sturm, P. Leicht, R. Arnold, B. Goke, and M. Katschinski. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36) amide in humans. J. Clin. Invest. 101: 1421-1430, 1998.
14. Tang-Christensen, M., P. J. Larsen, R. Goke, A. Fink-Jensen, D. S. Jessop, M. Moller, and S. P. Sheikh. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R848-R856, 1996.
15. Turton, M. D., D. O'Shea, I. Gunn, S. A. Beak, C. M. Edwards, K. Meeran, S. J. Choi, G. M. Taylor, M. M. Heath, P. D. Lambert, J. P. Wilding, D. M. Smith, M. A. Ghatei, J. Herbert, and S. R. Bloom. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1996.
16. Welch, I., K. Saunders, and N. W. Read. Effect of ileal and intravenous infusions of fat emulsions on feeding and satiety in human volunteers. Gastroenterology 89: 1293-1297, 1985.
17. Welch, I. M., C. P. Sepple, and N. W. Read. Comparisons of the effects on satiety and eating behaviour of infusion of lipid into the different regions of the small intestine. Gut 29: 306-311, 1988.